AI is changing how medicine works, from imaging to patient messaging, and states are racing to decide whether patients must be told when algorithms play a role. This piece looks at why disclosure matters, how privacy rules like HIPAA intersect with AI, and the patchwork of state laws shaping transparency. I’ll walk through the tradeoffs for patients and providers and highlight key state actions that are already reshaping clinical practice.
Artificial intelligence now supports diagnostic imaging, clinical decision tools, and back office workflows, helping clinicians work faster and reach more people. Yet the rise of these systems raises a straightforward question: should patients be informed when AI influences their care? Public trust matters more than ever because people expect to know when technology affects decisions that touch their health.
There is no single federal rule forcing broad AI disclosure across healthcare, so states are stepping in with varied approaches. Some require explicit notices when generative AI crafts patient messages, while others set transparency and accountability standards for systems that affect coverage or care access. That patchwork means healthcare organizations must track a shifting regulatory landscape instead of relying on one national standard.
Transparency is not just paperwork. When patients understand how decisions are made, they are more likely to follow treatment plans and stay engaged with providers. Research shows hidden AI use can erode trust fast, even if the technology is accurate, because people value knowing how material choices about their care are decided. Disclosure builds a relationship where clinicians remain accountable and patients retain agency.
HIPAA does not directly regulate artificial intelligence, but its privacy and notice principles still apply in spirit. Covered entities must explain how protected health information is used and safeguarded, and opaque AI processing can undermine that duty. When AI systems analyze or generate clinical information using patient data, failing to disclose that use can leave patients unclear about how their information shapes outcomes.
Disclosure also ties directly to informed consent and clinical ethics. Patients have a right to understand factors that influence diagnosis, treatment, or billing decisions, and meaningful AI use fits squarely into those material considerations. Just as clinicians tell patients about new procedures or devices, they should explain significant AI involvement so people can ask questions and stay involved in their care.
STATE-LEVEL AI RULES SURVIVE — FOR NOW — AS SENATE SINKS MORATORIUM DESPITE WHITE HOUSE PRESSURE
States are taking different tacks, but many start with the same idea: increased transparency when technology affects access or outcomes. California’s approach requires clinics and physician offices that use generative AI for patient communications to add clear disclaimers and a way to reach a human clinician. That simple step forces a human touchpoint and gives patients a path to clarification when automated messages slip into clinical conversations.
AI TOOLS COULD WEAKEN DOCTORS’ SKILLS IN DETECTING COLON CANCER, STUDY SUGGESTS
Other states focus on high-impact use cases like utilization review, coverage decisions, and claims processing. For example, some rules require licensed professionals to retain final authority on medical necessity determinations even when AI is used to flag or triage cases. Safeguards against algorithmic bias and requirements for human review are becoming common where AI materially influences whether someone gets care.
MORE AMERICANS ARE TURNING TO AI FOR HEALTH ADVICE
Colorado and Utah have laws targeting systems that materially influence approvals or therapeutic interactions, demanding both disclosure and protections against discrimination. Several additional states are considering or enforcing similar rules aimed at ensuring human oversight and clearer notice when automated systems shape access to services. That trend signals a broader expectation: transparency will be part of responsible AI governance in healthcare.
For healthcare providers, the practical work is clear: align disclosure practices across clinical, administrative, and digital systems and train staff to explain when AI tools are in use. For patients, expect more visible notices in messages, coverage letters, and portals that explain when automation played a role. Neither innovation nor efficiency needs to suffer when transparency is treated as part of clinical care quality.
